Article | Published:

The association between the legalization of recreational marijuana and both small for gestational age births and NICU admissions in Colorado

Abstract

Objective

To determine the association between recreational marijuana legalization and both small for gestational age (SGA) births and neonatal ICU (NICU) admissions in Colorado.

Study Design

Using interrupted time series analysis, we compared the incidence of SGA births and NICU admissions pre-/post-recreational marijuana legalization. Secondary analysis adjusted for marijuana outlet density (MOD) in maternal county of residence.

Results

We analyzed 269,922 mother–infant dyads. SGA birth risk dropped 7% immediately post-legalization (p= 0.04), but there was no slope difference between cohorts. SGA birth risk for high MOD dyads was 1.4x that of dyads with no outlets (p < 0.001) and 1.2x that of low MOD dyads (p= 0.002). There was no immediate effect on NICU admission risk, but the slope increased 1%/month post-legalization (p < 0.001) including a 1%/month increase for low MOD and 3%/month for high MOD dyads.

Conclusions

Incidence of SGA births in Colorado did not change following recreational marijuana legalization. NICU admissions increased post-legalization.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Ethics declarations

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. 1.

    Brown QL, Sarvet AL, Shmulewitz D, Martins SS, Wall MM, Hasin DS. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002-2014. JAMA. 2017;317:207–9.

  2. 2.

    Coleman-Cowger VH, Pickworth WB, Lordo RA, Peters EN. Cigar and marijuana blunt use among pregnant and nonpregnant women of reproductive age in the United States, 2006-2016. Am J Public Health. 2018;108:1073–5.

  3. 3.

    Young-Wolff KC, Tucker LY, Alexeeff S, Armstrong MA, Conway A, Weisner C, et al. Trends in self-reported and biochemically tested marijuana use among pregnant females in California from 2009-2016. JAMA. 2017;318:2490–1.

  4. 4.

    Marijuana use during pregnancy and lactation. Committee Opinion No. 722. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;130:e205–9.

  5. 5.

    Jarlenski M, Zank J, Tarr J, Chang JC. Public health messages about perinatal marijuana use in an evolving policy context. Subst Abus. 2017;38:48–54.

  6. 6.

    Dickson B, Mansfield C, Guiahi M, Allshouse AA, Borgelt LM, Sheeder J, et al. Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstet Gynecol. 2018;131:1031–8.

  7. 7.

    Jarlenski M, Koma JW, Zank J, Bodnar LM, Bogen DL, Chang JC. Trends in perception of risk of regular marijuana use among US pregnant and nonpregnant reproductive-aged women. Am J Obstet Gynecol. 2017;217:705–7.

  8. 8.

    Mark K, Gryczynski J, Axenfeld E, Schwartz RP, Terplan M. Pregnant Women’s current and intended cannabis use in relation to their views toward legalization and knowledge of potential harm. J Addict Med. 2017;11:211–6.

  9. 9.

    Conner SN, Bedell V, Lipsey K, Macones GA, Cahill AG, Tuuli MG. Maternal marijuana use and adverse neonatal outcomes: a systematic review and meta-analysis. Obstet Gynecol. 2016;128:713–23.

  10. 10.

    Gunn JK, Rosales CB, Center KE, Nunez A, Gibson SJ, Christ C, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6:e009986.

  11. 11.

    English DR, Hulse GK, Milne E, Holman CD, Bower CI. Maternal cannabis use and birth weight: a meta-analysis. Addiction. 1997;92:1553–60.

  12. 12.

    Crume TL, Juhl AL, Brooks-Russell A, Hall KE, Wymore E, Borgelt LM. Cannabis use during the perinatal period in a state with legalized recreational and medical marijuana: the association between maternal characteristics, breastfeeding patterns, and neonatal outcomes. J Pedia. 2018;197:90–6.

  13. 13.

    Colorado Department of Local Affairs, State Demography Office. Colorado population estimates by county, 2000–2016. Denver, CO: Author. 2017.

  14. 14.

    Colorado Department of Public Safety, Division of Criminal Justice, Office of Research and Statistics. Marijuana Legalization in Colorado: Early Findings. Denver, CO: Author. 2016.

  15. 15.

    Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pedia. 2013;13:59.

  16. 16.

    Popova S, Giesbrecht N, Bekmuradov D, Patra J. Hours and days of sale and density of alcohol outlets: impacts on alcohol consumption and damage: a systematic review. Alcohol Alcohol. 2009;44:500–16.

  17. 17.

    Penfold RB, Zhang F. Use of interrupted time series analysis in evaluating health care quality improvements. Acad Pedia. 2013;13(6 Suppl):S38–44.

  18. 18.

    Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27:299–309.

  19. 19.

    McCullough RE, Reeves JT. Fetal growth retardation and increased infant mortality at high altitide. Arch Environ Health. 1977;32:36–9.

  20. 20.

    Gonzales GF, Steenland K, Tapia V. Maternal hemoglobin level and fetal outcome at low and high altitudes. Am J Physiol Regul Integr Comp Physiol. 2009;297:R1477–85.

  21. 21.

    Ko JY, Tong VT, Bombard JM, Hayes DK, Davy J, Perham-Hester KA. Marijuana use during and after pregnancy and association of prenatal use on birth outcomes: A population-based study. Drug Alcohol Depend. 2018;187:72–8.

  22. 22.

    Metz TD, Allshouse AA, Hogue CJ, Goldenberg RL, Dudley DJ, Varner MW, et al. Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity. Am J Obstet Gynecol. 2017;217:478e1–8.

  23. 23.

    Dotters-Katz SK, Smid MC, Manuck TA, Metz TD. Risk of neonatal and childhood morbidity among preterm infants exposed to marijuana. J Matern Fetal Neonatal Med. 2017;30:2933–9.

  24. 24.

    Warshak CR, Regan J, Moore B, Magner K, Kritzer S, Van Hook J. Association between marijuana use and adverse obstetrical and neonatal outcomes. J Perinatol. 2015;35:991–5.

  25. 25.

    Mark K, Desai A, Terplan M. Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes. Arch Women’s Ment Health. 2016;19:105–11.

  26. 26.

    Brown SJ, Mensah FK, Ah Kit J, Stuart-Butler D, Glover K, Leane C, et al. Use of cannabis during pregnancy and birth outcomes in an Aboriginal birth cohort: a cross-sectional, population-based study. BMJ Open. 2016;6:e010286.

  27. 27.

    Benevenuto SG, Domenico MD, Martins MA, Costa NS, de Souza AR, Costa JL, et al. Recreational use of marijuana during pregnancy and negative gestational and fetal outcomes: An experimental study in mice. Toxicology. 2017;376:94–101.

  28. 28.

    Norgaard M, Nielsson MS, Heide-Jorgensen U. Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study. Subst Abus: Res Treat. 2015;9(Suppl 2):5–11.

  29. 29.

    Patrick SW, Dudley J, Martin PR, Harrell FE, Warren MD, Hartmann KE, et al. Prescription opioid epidemic and infant outcomes. Pediatrics. 2015;135:842–50.

  30. 30.

    Yazdy MM, Desai RJ, Brogly SB. Prescription opioids in pregnancy and birth outcomes: a review of the literature. J Pediatr Genet. 2015;4:56–70.

  31. 31.

    Patrick SW, Davis MM, Lehman CU, Cooper WO. Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol. 2015;35:667.

  32. 32.

    Tolia VN, Patrick SW, Bennett MM, Murthy K, Sousa J, Smith PB, et al. Increasing incidence of the neonatal abstinence syndrome in U.S. neonatal ICUs. N Engl J Med. 2015;372:2118–26.

  33. 33.

    Villapiano NL, Winkelman TN, Kozhimannil KB, Davis MM, Patrick SW. Rural and urban differences in neonatal abstinence syndrome and maternal opioid use, 2004 to 2013. JAMA Pedia. 2017;171:194–6.

  34. 34.

    Kozhimannil KB, Chantarat T, Ecklund AM, Henning-Smith C, Jones C. Maternal opioid use disorder and neonatal abstinence syndrome among rural US residents, 2007-2014. J Rural Health. 2019;35:122–32.

  35. 35.

    Livingston MD, Barnett TE, Delcher C, Wagenaar AC. Recreational cannabis legalization and opioid-related deaths in Colorado, 2000-2015. Am J Public Health. 2017;107:1827–9.

  36. 36.

    QuickStats. Changes* in late preterm birth rates,(dagger) by state - national vital statistics system, United States, 2014 and 2016. MMWR Morb Mortal Wkly Rep. 2018;67:696.

Download references

Funding

This work was Supported by NIH/NCATS Colorado CTSI Grant Number ULI TR001082.

Author information

JL is a Pediatric Hospitalist who assisted with study design and data analysis. He has approved the final manuscript as submitted. AM is a biostatistician who assisted with study design and data analysis. She has approved the final manuscript as submitted. AB assisted with study design and data analysis. She has approved the final manuscript as submitted. IF assisted with study design and data analysis. He has approved the final manuscript as submitted. ES assisted with study design and data analysis. She has approved the final manuscript as submitted. EW is a neonatologist who assisted with study design and data analysis. She has approved the final manuscript as submitted.

Conflict of interest

The authors declare that they have no conflict of interest.

Correspondence to Justin Lockwood.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1
Fig. 2
Fig. 3